| Product Code: ETC12942644 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam mRNA Therapeutics Contract Development Manufacturing Market - Industry Life Cycle |
3.4 Vietnam mRNA Therapeutics Contract Development Manufacturing Market - Porter's Five Forces |
3.5 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
3.6 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in healthcare infrastructure in Vietnam |
4.2.2 Growing demand for mRNA therapeutics for various diseases in the region |
4.2.3 Rising focus on research and development activities in the pharmaceutical sector |
4.3 Market Restraints |
4.3.1 Lack of skilled workforce specialized in mRNA therapeutics manufacturing |
4.3.2 Regulatory challenges and compliance requirements in the mRNA therapeutics sector |
4.3.3 Limited awareness and adoption of mRNA therapeutics in Vietnam |
5 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Trends |
6 Vietnam mRNA Therapeutics Contract Development Manufacturing Market, By Types |
6.1 Vietnam mRNA Therapeutics Contract Development Manufacturing Market, By Service Type |
6.1.1 Overview and Analysis |
6.1.2 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Service Type, 2021 - 2031F |
6.1.3 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Process Development, 2021 - 2031F |
6.1.4 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Analytical Testing, 2021 - 2031F |
6.1.5 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Manufacturing, 2021 - 2031F |
6.1.6 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Formulation Development, 2021 - 2031F |
6.1.7 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Regulatory Support, 2021 - 2031F |
6.2 Vietnam mRNA Therapeutics Contract Development Manufacturing Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By mRNA Vaccines, 2021 - 2031F |
6.2.3 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By mRNA Therapeutics, 2021 - 2031F |
6.2.4 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By mRNA Drug Delivery, 2021 - 2031F |
6.2.5 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Personalized Medicine, 2021 - 2031F |
6.2.6 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Protein Replacement Therapy, 2021 - 2031F |
6.3 Vietnam mRNA Therapeutics Contract Development Manufacturing Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Infectious Diseases, 2021 - 2031F |
6.3.3 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Cancer Treatment, 2021 - 2031F |
6.3.4 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Rare Diseases, 2021 - 2031F |
6.3.5 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Genetic Disorders, 2021 - 2031F |
6.3.6 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Autoimmune Diseases, 2021 - 2031F |
6.4 Vietnam mRNA Therapeutics Contract Development Manufacturing Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.4.3 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Biotechnology Firms, 2021 - 2031F |
6.4.4 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Contract Manufacturing Organizations, 2021 - 2031F |
6.4.5 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.6 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Clinical Research Organizations, 2021 - 2031F |
6.5 Vietnam mRNA Therapeutics Contract Development Manufacturing Market, By Technology |
6.5.1 Overview and Analysis |
6.5.2 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Lipid Nanoparticles, 2021 - 2031F |
6.5.3 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By In Vitro Transcription, 2021 - 2031F |
6.5.4 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By Encapsulation Methods, 2021 - 2031F |
6.5.5 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By CRISPR Technology, 2021 - 2031F |
6.5.6 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Revenues & Volume, By AI-Based Quality Control, 2021 - 2031F |
7 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Import-Export Trade Statistics |
7.1 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Export to Major Countries |
7.2 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Imports from Major Countries |
8 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Key Performance Indicators |
8.1 Number of clinical trials involving mRNA therapeutics in Vietnam |
8.2 Percentage increase in research funding allocated to mRNA therapeutics development |
8.3 Number of partnerships and collaborations between local and international pharmaceutical companies in mRNA therapeutics segment |
9 Vietnam mRNA Therapeutics Contract Development Manufacturing Market - Opportunity Assessment |
9.1 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Service Type, 2021 & 2031F |
9.2 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 Vietnam mRNA Therapeutics Contract Development Manufacturing Market - Competitive Landscape |
10.1 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Revenue Share, By Companies, 2024 |
10.2 Vietnam mRNA Therapeutics Contract Development Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here